Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
IDR 402
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. It owns and operates 7 hospitals. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell